ArticleHeliyon2024

TP53 mitigates cisplatin resistance in non-small cell lung cancer by mediating the effects of resistant cell-derived exosome mir-424-5p.

Yan Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.